Navigation Links
Antibiotics can cause pervasive, persistant changes to microbiota in human gut
Date:11/18/2008

MBL, WOODS HOLE, MAUsing a novel technique developed by Mitchell Sogin of the Marine Biological Laboratory (MBL) to identify different types of bacteria, scientists have completed the most precise survey to date of how microbial communities in the human gut respond to antibiotic treatment.

Sogin, director of the MBL's Josephine Bay Paul Center, and Susan Huse of the MBL, along with David Relman and Les Dethlefsen of Stanford University, identified pervasive changes in the gut microbial communities of three healthy humans after a five-day course of the antibiotic Ciprofloxacin. Their results are reported in the Nov. 18 issue of PloS Biology.

Using very conservative criteria, the scientists identified at least 3,300 to 5,700 different taxa (genetically distinct types) of bacteria in the human distal gut, and antibiotic treatment influenced the abundance of about a third of those taxa.

"You clearly get shifts in the structure of the microbial community with antibiotic treatment," says Sogin. "Some bacteria that were in low abundance prior to treatment may become more abundant, and bacteria that were dominant may decrease in abundance. When you get these shifts, they may be persistent. Some individuals may recover quickly, and others won't recover for many months."

In all the individuals tested in this study, the bacterial community recovered and closely resembled its pre-treatment state within four weeks after the antibiotic course ended, but several bacterial taxa failed to recover within six months.

This raises questions about the health effects of perturbations to the human-microbial symbiosis in the gut, such as may occur with antibiotic treatment. Because specific microbial populations mediate many chemical transformations in the gutand previous studies have related these processes to cancer and obesity, among other conditionschanges in the composition of the gut microbiota could have important, but as ye
'/>"/>

Contact: Diana Kenney
dkenney@mbl.edu
508-289-7139
Marine Biological Laboratory
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Antibiotics Not Always Best Bet for Battling Childhood Ear Infections
2. Ear infection superbug discovered to be resistant to all pediatric antibiotics
3. Antibiotics May Not Help Mens Chronic Pelvic Pain: Harvard Doctors Discuss Alternatives
4. Advanced Life Sciences to Participate in Antibiotics Expert Panel at the 10th Annual BIO CEO & Investor Conference
5. DNA with a twist: New company to search for cancer drugs and antibiotics
6. Antibiotics Do Little for Inner Ear Infections
7. Biannual Antibiotics May Cut Major Cause of Blindness in Africa
8. Synthetic peptoids hold forth promise for new antibiotics
9. Dont Prescribe Antibiotics for Adult Sinus Woes
10. Green Tea Boosts Antibiotics for Superbugs
11. Gator Blood May Be New Source of Antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ntists may not be able to tell a good book by its ...ld book by its smell. In a report in ACS, Analyti...ibe development of a new test that can measure the...documents based on their smell. The nondestructive...serve a range of prized paper-based objects, some ...
(Date:12/2/2009)...ampions Biotechnology, Inc. (OTC Bulletin Board: C...h a predictive preclinical platform aimed at accel... oncology drugs, has established an exclusive lice...Ltd., Tel Aviv University,s wholly owned technolog...ncompasses the development and commercialization o...
(Date:12/2/2009)... MyCareTeam, Inc., a leading vend...ftware, has released the newest version of its sof...rtension, congestive heart failure and weight mana...abetes monitoring features. , ...reTeam, Inc., a leading vendor of Internet-based c...
(Date:12/2/2009)... , ARLINGTON, Va., Dec. 2 Fro...life that give us meaning, joy and peace, the LIFE...ever contest conducted using the popular photo-sha...e viewed in a video montage on the LIFE Foundation.... ,, Contestants submitted one photo and a cap...
(Date:12/2/2009)... , MORRISTOWN, N.J., Dec. 2 /PRNewswire-FirstCa... today announced that the Federal Trade Commission...ublic comment relating to Watson,s pending acquisi... early termination of the Hart Scott Rodino waitin...the transaction. The parties have now obtained al...
Breaking Medicine News(10 mins):Health News:Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2
...POLIS, Dec. 8 A mural on a 1,230-foot-long wall,a...Indianapolis, has achieved,recognition as a new Gu...fication projects completed in partnership with Ke...ld last May. , Lilly and KIB submitted the m...
...LE, Calif., Dec. 8 Expresso Fitness(R), the leadi...tness systems, announced today,that it has complet...$14M.,The capital will be used to fuel Expresso,s ...xpresso. The equity round was,joined by all exist...
...EE, Dec. 8 Aurora Health Care and Associated Surg...premier ambulatory surgery centers, announced toda... the two organizations jointly operate the surgery...nce the quality of care for patients," said James ...
...rts are recommending that a malaria vaccine progre...l of the RTS, S/AS01E malaria vaccine among 5-17 m... Kenya, which is reported today in the New Englan...inistration of the RTS, S/AS02 malaria vaccine thr...
..., Dec. 8 Americans United for Life (AUL) condemns...e state have a right to die by assisted suicide, a...ontana State Supreme Court. , , Dr. Charmai...ses in Oregon where patients are denied state insu...
...ic Injury Protection Program Expands Benefits , ...s Affairs (VA) announced some severely injured mil...improvements to the Servicemembers, Group Life Ins...y personnel and their families," said Secretary of...
Other Medicine News:Health News:Lilly Global Day of Service Receives National and Local Recognition 2Health News:Lilly Global Day of Service Receives National and Local Recognition 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 2Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 4Health News:Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 3Health News:Americans United For Life Denounces Montana Court's Assisted Suicide Decision, Urges Appeal 2Health News:VA Announces Changes to Servicemembers' Group Life Insurance 2
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PR...a, including a late-breaking presentation on Tasig...chronic myeloid leukemia, demonstrate the strength...g the care of patients. ,, The new data, at th... Meeting and Exposition, highlight the company,s c...
(Date:12/1/2009)..., , NEW YORK, Dec . 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ... ,, http://www.reportlinker.com/p0164247/Insul..., Insulin pumps, also called Continuous Subcutan...ol over diabetes, when compared to other forms of ...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ...eview ,, http://www.reportlinker.com/p0164366....html ,, Over the years, Liquid Chromatography...ences, pharmaceuticals, food and beverage, researc...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Overweight kids experience more loneliness anxiety MU study finds 50660 1Overweight kids experience more loneliness anxiety MU study finds 50660 2Natural compound stops retinopathy 9106 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 2
...k Buyer for Marketed Parenteral Product Ganite(R),...ated,(Nasdaq: GNTA ) today announced that the Com...on covering novel pharmaceutical gallium compositi...ent Office. Issued U.S.,Patent 7,354,952 extends t... franchise of oral gallium-containing products tha...
...Developed and Validated Clinically at Clinical Lab...Laboratory at the University of Ca...cs Expects Three Tests Applying its MicroRNA Techn...ertified Labs During 2008, REHOVOT, Israel and JE... Ltd. (Nasdaq: ROSG ), a leader in,the development...
Other Medicine Technology:Genta Receives Key Patent Related to Oral Gallium Compound G4544 2Genta Receives Key Patent Related to Oral Gallium Compound G4544 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 2Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 4
Orrison's Medical Imaging Consultant for PDA
Schwartz Principles of Surgery PDA Edition
Sanford Guide to HIV/AIDS Therapy 2004
LyteMeister
Medicine Products: